RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $343,537 (98.1% shares, 1.9% debt)

Holdings (35)

ALNY Alnylam Pharmaceuticals Inc 14.3%

Value ($000) $49,268 Shares 411,016 Est. Cost $96.60 Unrealized +23.7%

BCRX BioCryst Pharmaceuticals Inc 9.8%

Value ($000) $33,762 Shares 2,261,361 Est. Cost $11.05 Unrealized +2.9%

— Kite Pharma Inc 7.1%

Value ($000) $24,388 Shares 400,000 Est. Cost $57.88 Unrealized —

— Achillion Pharmaceuticals Inc 6.5%

Value ($000) $22,287 Shares 2,515,433 Est. Cost $11.05 Unrealized —

INCY Incyte Corp 5.9%

Value ($000) $20,321 Shares 195,000 Est. Cost $103.51 Unrealized 0.0%

— La Jolla Pharmaceutical Company Cmn Di 5.6%

Value ($000) $19,131 Shares 780,547 Est. Cost $24.51 Unrealized —

— Arrowhead Research Corp 5.3%

Value ($000) $18,304 Shares 2,560,000 Est. Cost $7.37 Unrealized —

— Dicerna Pharmaceuticals Inc 5.2%

Value ($000) $17,854 Shares 1,279,886 Est. Cost $15.90 Unrealized —

— Agenus Inc 5.2%

Value ($000) $17,717 Shares 2,052,915 Est. Cost $8.63 Unrealized —

— bluebird bio Inc 5.1%

Value ($000) $17,679 Shares 105,000 Est. Cost $123.04 Unrealized —

— Dyax Corp 4.3%

Value ($000) $14,817 Shares 559,141 Est. Cost $14.06 Unrealized —

— Five Prime Therapeutics Inc 4.1%

Value ($000) $13,921 Shares 560,437 Est. Cost $24.84 Unrealized —

— Celldex Therapeutics Inc 3.5%

Value ($000) $11,893 Shares 471,554 Est. Cost $25.22 Unrealized —

— Targacept Inc 2.2%

Value ($000) $7,437 Shares 2,665,643 Est. Cost $2.63 Unrealized —

— La Jolla Pharmaceutical Co 2.0%

Value ($000) $6,953 Shares 283,700 Est. Cost $18.45 Unrealized —

BMY Bristol-Myers Squibb Co 1.9%

Value ($000) $6,485 Shares 97,454 Est. Cost $46.01 Unrealized 0.0%

— Bristol Myers Squibb Co 01/15/2016 CALL 60 1.8%

Value ($000) $6,113 Shares 7,500 Est. Cost — Unrealized —

— Symmetry Surgical Inc 1.8%

Value ($000) $6,111 Shares 700,851 Est. Cost $8.72 Unrealized —

— Corium International Inc 1.4%

Value ($000) $4,860 Shares 355,007 Est. Cost $13.69 Unrealized —

— NewLink Genetics Corp 1.3%

Value ($000) $4,427 Shares 100,000 Est. Cost $44.27 Unrealized —

TLT iShares 20+ Year Treasury Bond ETF 1.1%

Value ($000) $3,876 Shares 33,000 Est. Cost $117.45 Unrealized —

— United States Oil ETF 1.0%

Value ($000) $3,280 Shares 165,000 Est. Cost $19.88 Unrealized —

— Presbia Plc 0.8%

Value ($000) $2,877 Shares 350,000 Est. Cost $7.39 Unrealized —

— Invuity Inc 0.7%

Value ($000) $2,330 Shares 165,000 Est. Cost $14.12 Unrealized —

— Lipocine Inc 0.5%

Value ($000) $1,796 Shares 209,333 Est. Cost $5.26 Unrealized —

— CytRx Corp 0.5%

Value ($000) $1,662 Shares 446,714 Est. Cost $2.74 Unrealized —

— Repros Therapeutics Inc 0.5%

Value ($000) $1,640 Shares 229,364 Est. Cost $9.97 Unrealized —

— Biopharmx Corp 0.3%

Value ($000) $949 Shares 370,636 Est. Cost $2.56 Unrealized —

— Nivalis Therapeutics Inc 0.1%

Value ($000) $455 Shares 30,000 Est. Cost $15.17 Unrealized —

ADAPY Adaptimmune Therapeutics-adr 0.1%

Value ($000) $367 Shares 20,000 Est. Cost $18.35 Unrealized —

— Meridian Bioscience Inc. VIVO 10/16/2015 CALL 20 0.1%

Value ($000) $260 Shares 3,756 Est. Cost — Unrealized —

— Zogenix Inc 0.1%

Value ($000) $192 Shares 114,128 Est. Cost $1.68 Unrealized —

— Valeant Pharmaceuticals Intl VRX 10/16/2015 CALL 260 0.0%

Value ($000) $78 Shares 150 Est. Cost — Unrealized —

— Fortress Biotech Inc 0.0%

Value ($000) $40 Shares 11,917 Est. Cost $3.36 Unrealized —

BRK/B Berkshire Hathaway Inc 0.0%

Value ($000) $7 Shares 50 Est. Cost $147.14 Unrealized -3.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals Inc	411,016	$49,268	14.3%	$96.60	+23.7%	COM	02043Q107
BCRX	BioCryst Pharmaceuticals Inc	2,261,361	$33,762	9.8%	$11.05	+2.9%	COM	09058V103
—	Kite Pharma Inc	400,000	$24,388	7.1%	$57.88	—	COM	49803L109
—	Achillion Pharmaceuticals Inc	2,515,433	$22,287	6.5%	$11.05	—	COM	00448Q201
INCY	Incyte Corp	195,000	$20,321	5.9%	$103.51	0.0%	COM	45337C102
—	La Jolla Pharmaceutical Company Cmn Di	780,547	$19,131	5.6%	$24.51	—	COM	0
—	Arrowhead Research Corp	2,560,000	$18,304	5.3%	$7.37	—	COM	042797209
—	Dicerna Pharmaceuticals Inc	1,279,886	$17,854	5.2%	$15.90	—	COM	253031108
—	Agenus Inc	2,052,915	$17,717	5.2%	$8.63	—	COM	00847G705
—	bluebird bio Inc	105,000	$17,679	5.1%	$123.04	—	COM	09609G100
—	Dyax Corp	559,141	$14,817	4.3%	$14.06	—	COM	26746E103
—	Five Prime Therapeutics Inc	560,437	$13,921	4.1%	$24.84	—	COM	33830X104
—	Celldex Therapeutics Inc	471,554	$11,893	3.5%	$25.22	—	COM	15117B103
—	Targacept Inc	2,665,643	$7,437	2.2%	$2.63	—	COM	87611R306
—	La Jolla Pharmaceutical Co	283,700	$6,953	2.0%	$18.45	—	COM	503459604
BMY	Bristol-Myers Squibb Co	97,454	$6,485	1.9%	$46.01	0.0%	COM	110122108
—	Bristol Myers Squibb Co 01/15/2016 CALL 60	7,500	$6,113	1.8%	—	—	Call	110122908
—	Symmetry Surgical Inc	700,851	$6,111	1.8%	$8.72	—	COM	87159G100
—	Corium International Inc	355,007	$4,860	1.4%	$13.69	—	COM	21887L107
—	NewLink Genetics Corp	100,000	$4,427	1.3%	$44.27	—	COM	651511107
TLT	iShares 20+ Year Treasury Bond ETF	33,000	$3,876	1.1%	$117.45	—	COM	464287432
—	United States Oil ETF	165,000	$3,280	1.0%	$19.88	—	COM	91232N108
—	Presbia Plc	350,000	$2,877	0.8%	$7.39	—	COM	G7234P100
—	Invuity Inc	165,000	$2,330	0.7%	$14.12	—	COM	46187J205
—	Lipocine Inc	209,333	$1,796	0.5%	$5.26	—	COM	53630X104
—	CytRx Corp	446,714	$1,662	0.5%	$2.74	—	COM	232828509
—	Repros Therapeutics Inc	229,364	$1,640	0.5%	$9.97	—	COM	76028H209
—	Biopharmx Corp	370,636	$949	0.3%	$2.56	—	COM	09072X101
—	Nivalis Therapeutics Inc	30,000	$455	0.1%	$15.17	—	COM	65481J109
ADAPY	Adaptimmune Therapeutics-adr	20,000	$367	0.1%	$18.35	—	COM	00653A107
—	Meridian Bioscience Inc. VIVO 10/16/2015 CALL 20	3,756	$260	0.1%	—	—	Call	589584901
—	Zogenix Inc	114,128	$192	0.1%	$1.68	—	COM	98978L204
—	Valeant Pharmaceuticals Intl VRX 10/16/2015 CALL 260	150	$78	0.0%	—	—	Call	91911K902
—	Fortress Biotech Inc	11,917	$40	0.0%	$3.36	—	COM	34960Q109
BRK/B	Berkshire Hathaway Inc	50	$7	0.0%	$147.14	-3.1%	COM	084670702